For: | Xu J, Yang CH, Chen XY, Li XH, Dai M, Xiao SD. A subset of ulcerative colitis with positive proteinase-3 antineutrophil cytoplasmic antibody. World J Gastroenterol 2008; 14(45): 7012-7015 [PMID: 19058341 DOI: 10.3748/wjg.14.7012] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i45/7012.htm |
Number | Citing Articles |
1 |
Yuki Aoyama, Tomoki Inaba, Sakuma Takahashi, Hisae Yasuhara, Sakiko Hiraoka, Takeshi Morimoto, Hugh Shunsuke Colvin, Masaki Wato, Midori Ando, Satoko Nakamura, Koichi Mizobuchi, Hiroyuki Okada. Anti-proteinase 3 antineutrophil cytoplasmic antibody reflects disease activity and predicts the response to steroid therapy in ulcerative colitis. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01903-5
|
2 |
Johannes Schulte-Pelkum, Antonella Radice, Gary L. Norman, Marcos Lόpez Hoyos, Gabriella Lakos, Carol Buchner, Lucile Musset, Makoto Miyara, Laura Stinton, Michael Mahler. Novel Clinical and Diagnostic Aspects of Antineutrophil Cytoplasmic Antibodies. Journal of Immunology Research 2014; 2014: 1 doi: 10.1155/2014/185416
|
3 |
Yan Xu, Fei Xu, Wenjie Li, Mengting Li, Shouquan Dong, Yupeng Zhang, Gary L. Norman, Qiu Zhao, Lan Liu. The diagnostic role and clinical association of serum proteinase 3 anti-neutrophil cytoplasmic antibodies in Chinese patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2020; 55(7): 806 doi: 10.1080/00365521.2020.1781926
|
4 |
Maria Teresa Arias-Loste, Geovana Bonilla, Irene Moraleja, Michael Mahler, Miguel Angel Mieses, Beatriz Castro, Montserrat Rivero, Javier Crespo, Marcos López-Hoyos. Presence of Anti-proteinase 3 Antineutrophil Cytoplasmic Antibodies (Anti-PR3 ANCA) as Serologic Markers in Inflammatory Bowel Disease. Clinical Reviews in Allergy & Immunology 2013; 45(1): 109 doi: 10.1007/s12016-012-8349-4
|
5 |
Rehana Saleem, Michael Oliver, Anthony Rowbottom, Laurie Solomon. Antineutrophil cytoplasmic antibodies: two cases of changing antigenic specificity. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2012; 49(3): 295 doi: 10.1258/acb.2011.011100
|
6 |
Gregorios Christodoulidis, Konstantinos Perivoliotis, Anastasios Manolakis, Alexandros Diamantis, Apostolos Koffas, Dimitrios Magouliotis, Vasiliki Pappi, Dimitrios Zacharoulis. Ulcerative Colitis in Hematological Malignancies: Paraneoplastic Manifestation or Coincidental Bystander?. Case Reports in Gastrointestinal Medicine 2020; 2020: 1 doi: 10.1155/2020/6135425
|
7 |
Carmen Andalucía, Laura Martínez-Prat, Chelsea Bentow, Mary Ann Aure, Michael P. Horn, Michael Mahler. Clinical Validity of Anti-Proteinase 3 Antibodies in Patients with Inflammatory Bowel Disease: A Short Meta-Analysis. Diagnostics 2023; 13(24): 3682 doi: 10.3390/diagnostics13243682
|
8 |
Bo-Lin Ho, Fang-Jung Yu, Chiou-Lian Lai, Hsin-Hsin Lin. Avellis syndrome as presenting manifestation of ulcerative colitis. Journal of the Neurological Sciences 2013; 325(1-2): 160 doi: 10.1016/j.jns.2012.11.015
|
9 |
Masayoshi Yamamoto, Manabu Inoue, Naoko Tachibana, Koji Tsuzaki, Yoko Shibata, Toshiaki Hamano. Non-granulomatous myositis in a patient with ulcerative colitis who showed symptoms resembling gastrocnemius myalgia syndrome. Rinsho Shinkeigaku 2017; 57(2): 71 doi: 10.5692/clinicalneurol.cn-000891
|
10 |
Senka Dobric, Dragan Popovic, Milos Nikolic, Sladjana Andrejevic, Milan Spuran, Branka Bonaci-Nikolic. Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis. Clinical Chemistry and Laboratory Medicine 2012; 50(3) doi: 10.1515/cclm.2011.797
|
11 |
Juliana Goldbaum Crescente, Alessandra Dellavance, Marcio Augusto Diniz, Flair Jose Carrilho, Luis Eduardo Coelho de Andrade, Eduardo Luiz Rachid Cançado. Antineutrophil cytoplasmic antibody profiles differ according to type of primary sclerosing cholangitis and autoimmune hepatitis. Clinics 2021; 76: e2228 doi: 10.6061/clinics/2021/e2228
|
12 |
Michael Mahler, Dimitrios P. Bogdanos, Polychronis Pavlidis, Marvin J. Fritzler, Elena Csernok, Jan Damoiseaux, Chelsea Bentow, Zakera Shums, Alastair Forbes, Gary L. Norman. PR3-ANCA: A promising biomarker for ulcerative colitis with extensive disease. Clinica Chimica Acta 2013; 424: 267 doi: 10.1016/j.cca.2013.06.005
|
13 |
Giacomo Ramponi, Marco Folci, Maria De Santis, Jan G.M.C. Damoiseaux, Carlo Selmi, Enrico Brunetta. The biology, pathogenetic role, clinical implications, and open issues of serum anti-neutrophil cytoplasmic antibodies. Autoimmunity Reviews 2021; 20(3): 102759 doi: 10.1016/j.autrev.2021.102759
|
14 |
Stephanie Van Biervliet, Carolien Bonroy, Saskia Vande Velde, Ruth De Bruyne, Myriam Van Winckel, Harald Peeters, Joris Delanghe, Veronique Stove, Martine De Vos. C‐ANCA/Proteinase 3–Positive Colitis in Children. Journal of Pediatric Gastroenterology and Nutrition 2013; 57(4): 489 doi: 10.1097/MPG.0b013e31829d4e9e
|